Metabolism of 2-acylglycerol in rabbit and human platelets. Involvement of monoacylglycerol lipase and fatty acid amide hydrolase

References

• Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258: 1946–1949
   PubMed Web of Science ®Google Scholar
• Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995; 50: 83–90
   PubMed Web of Science ®Google Scholar
• Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995; 215: 89–97
   PubMed Web of Science ®Google Scholar
• Bradshaw HB, Walker JM. The expanding field of cannabimimetic and related lipid mediators. Br J Pharmacol 2005; 144: 459–465
   PubMed Web of Science ®Google Scholar
• Sugiura T, Kondo S, Kishimoto S, Miyashita T, Nakane S, Kodaka T, Suhara Y, Takayama H, Waku K. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J Biol Chem 2000; 275: 605–612
   PubMed Web of Science ®Google Scholar
• Freund TF, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003; 83: 1017–1066
   PubMed Web of Science ®Google Scholar
• Wilson RI, Nicoll RA. Endocannabinoid signaling in the brain. Science 2002; 296: 678–682
   PubMed Web of Science ®Google Scholar
• Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, Friedman H. The cannabinoid system and immune modulation. J Leukoc Biol 2003; 74: 486–496
   PubMed Web of Science ®Google Scholar
• Francischetti EA, de Abreu V. The endocannabinoid system: A new perspective for cardiometabolic risk control. Arq Bras Cardiol 2006; 87: 548–558
   Google Scholar
• Jarai Z, Wagner JA, Goparaju SK, Wang L, Razdan RK, Sugiura T, Zimmer AM, Bonner TI, Zimmer A, Kunos G. Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. Hypertension 2000; 35: 679–684
   PubMed Web of Science ®Google Scholar
• Lepicier P, Bibeau-Poirier A, Lagneux C, Servant MJ, Lamontagne D. Signaling pathways involved in the cardioprotective effects of cannabinoids. J Pharmacol Sci 2006; 102: 155–166
   Google Scholar
• Wagner JA, Varga K, Jarai Z, Kunos G. Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension 1999; 33: 429–434
   PubMed Web of Science ®Google Scholar
• Deutsch DG, Goligorsky MS, Schmid PC, Krebsbach RJ, Schmid HHO, Das SK, Dey SK, Arreaza G, Thorup C, Stefano G, et al. Production and Physiological Actions of Anandamide in the Vasculature of the Rat Kidney. J Clin Invest 1997; 100: 1538–1546
   PubMed Web of Science ®Google Scholar
• Varga K, Wagner JA, Bridgen DT, Kunos G. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 1998; 12: 1035–1044
   PubMed Web of Science ®Google Scholar
• Maccarrone M, Bari M, Menichelli A, Giuliani E, Del Principe D, Finazzi-Agro A. Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor. Eur J Biochem 2001; 268: 819–825
   PubMedGoogle Scholar
• Maccarrone M, Bari M, Menichelli A, Del Principe D, Agro AF. Anandamide activates human platelets through a pathway independent of the arachidonate cascade. FEBS Lett 1999; 447: 277–282
   PubMed Web of Science ®Google Scholar
• Braud S, Bon C, Touqui L, Mounier C. Activation of rabbit blood platelets by anandamide through its cleavage into arachidonic acid. FEBS Lett 2000; 471: 12–16
   PubMedGoogle Scholar
• Fasia L, Karava V, Siafaka-Kapadai A. Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter? Eur J Biochem 2003; 270: 3498–3506
   PubMedGoogle Scholar
• Basavarajappa BS. Critical enzymes involved in endocannabinoid metabolism. Protein Pept Lett 2007; 14: 237–246
   PubMed Web of Science ®Google Scholar
• Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 1996; 384: 83–87
   PubMed Web of Science ®Google Scholar
• Giang DK, Cravatt BF. Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci USA 1997; 94: 2238–2242
   PubMed Web of Science ®Google Scholar
• Goparaju SK, Kurahashi Y, Suzuki H, Ueda N, Yamamoto S. Anandamide amidohydrolase of porcine brain: cDNA cloning, functional expression and site-directed mutagenesis. Biochim Biophys Acta 1999; 1441: 77–84
   PubMed Web of Science ®Google Scholar
• Saario SM, Laitinen JT. Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors. Basic Clin Pharmacol Toxicol 2007; 101: 287–293
   PubMed Web of Science ®Google Scholar
• Goparaju SK, Ueda N, Taniguchi K, Yamamoto S. Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem Pharmacol 1999; 57: 417–423
   PubMed Web of Science ®Google Scholar
• Di Marzo V, Bisogno T, Sugiura T, Melck D, De Petrocellis L. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: Connections with anandamide. Biochem J 1998; 331(Pt 1)15–19
   Google Scholar
• Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Orlando P, Wagner JA, Kunos G. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem 1999; 264: 258–267
   PubMedGoogle Scholar
• Muccioli GG, Xu C, Odah E, Cudaback E, Cisneros JA, Lambert DM, Lopez Rodriguez ML, Bajjalieh S, Stella N. Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. J Neurosci 2007; 27: 2883–2889
   Google Scholar
• Dinh TP, Kathuria S, Piomelli D. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol Pharmacol 2004; 66: 1260–1264
   PubMed Web of Science ®Google Scholar
• Mor M, Rivara S, Lodola A, Plazzi PV, Tarzia G, Duranti A, Tontini A, Piersanti G, Kathuria S, Piomelli D. Cyclohexylcarbamic acid 3′- or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: Synthesis, quantitative structure-activity relationships, and molecular modeling studies. J Med Chem 2004; 47: 4998–5008
   PubMed Web of Science ®Google Scholar
• Deutsch DG, Lin S, Hill WA, Morse KL, Salehani D, Arreaza G, Omeir RL, Makriyannis A. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor. Biochem Biophys Res Commun 1997; 231: 217–221
   PubMed Web of Science ®Google Scholar
• Pinckard RN, Farr RS, Hanahan DJ. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J Immunol 1979; 123: 1847–1857
   PubMed Web of Science ®Google Scholar
• Siafaka-Kapadai A, Hanahan D. An endogenous inhibitor of PAF-induced platelet aggregation, isolated from rat liver, has been identified as free fatty acid. Biochim Biophys Acta 1993; 1166: 217–221
   PubMedGoogle Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Ekholm J, Tatsumi Y, Nouchi T, Hanahan DJ. The human platelet as a reproducible and sensitive cell for the detection and assay of platelet-activating factor. Anal Biochem 1992; 204: 79–84
   Google Scholar
• Siafaka-Kapadai A, Hanahan DJ, Javors MA. Oleic acid-induced Ca2+ mobilization in human platelets: Is oleic acid an intracellular messenger?. J Lipid Mediat Cell Signal 1997; 15: 215–232
   Google Scholar
• Dinh TP, Freund TF, Piomelli D. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. Chem Phys Lipids 2002; 121: 149–158
   PubMed Web of Science ®Google Scholar
• Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 2002; 99: 10819–10824
   PubMed Web of Science ®Google Scholar
• Karlsson M, Contreras JA, Hellman U, Tornqvist H, Holm C. cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J Biol Chem 1997; 272: 27218–27223
   PubMedGoogle Scholar
• Lagarde M. Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function. Prog Lipid Res 1988; 27: 135–152
   Google Scholar
• Bry K, Andersson LC, Kuusi T, Kinnunen PK. Monoacylglycerol hydrolase in human platelets. Biochim Biophys Acta 1979; 575: 121–127
   Google Scholar
• Chau LY, Tai HH. Monoglyceride and diglyceride lipases from human platelet microsomes. Biochim Biophys Acta 1988; 963: 436–444
   Google Scholar
• Saario SM, Savinainen JR, Laitinen JT, Jarvinen T, Niemi R. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochem Pharmacol 2004; 67: 1381–1387
   PubMed Web of Science ®Google Scholar
• Yamamoto S. Mammalian lipoxygenases: Molecular structures and functions. Biochim Biophys Acta 1992; 1128: 117–131
   PubMed Web of Science ®Google Scholar
• Fowler CJ. The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action. Br J Pharmacol. 2007; 152: 594–601
   PubMed Web of Science ®Google Scholar
• Piomelli D, Tarzia G, Duranti A, Tontini A, Mor M, Compton TR, Dasse O, Monaghan EP, Parrott JA, Putman D. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS Drug Rev 2006; 12: 21–38
   PubMedGoogle Scholar
• Bisogno T, Sepe N, Melck D, Maurelli S, De Petrocellis L, Di Marzo V. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem J 1997; 322(Pt 2)671–677
   PubMed Web of Science ®Google Scholar